Patent details

Basic Information

Publication number:

EP2016950

PCT Application Number:

Type:

European Patent Granted for LU

Legal Status:

Lapsed

Application number:

EP080166671

PCT Publication Number:

First applicant's nationality:

Translation Language:

EPO Publication Language:

English

English Title of Invention:

Pharmaceutical composition comprising an exendin-4 peptide

French Title of Invention:

Composition pharmaceutique comportant un peptide d'exendine-4

German Title of Invention:

Pharmazeutische Zusammensetzung mit einem Exendin-4-Peptid

SPC Number:

Dates

Filing date:

08/08/1997

Grant date:

05/01/2011

EP Publication Date:

05/01/2011

PCT Publication Date:

Claims Translation Received Date:

Translations Received Date (B1 EP Publication):

Translations Received Date (B2 EP Publication):

Translations Received Date (B3 EP Publication):

Publication date:

21/01/2009

EP B1 Publication Date:

05/01/2011

EP B2 Publication Date:

EP B3 Publication Date:

Lapsed date:

08/08/2011

Expiration date:

08/08/2017

Renunciation date:

Revocation date:

09/02/2018

Annulment date:

Owner

From:

08/08/1997

 

 

Name:

Amylin Pharmaceuticals Inc.

Address:

9360 Towne Centre Drive, San Diego, CA 92121, United States (US)

Inventor

1

Name:

Young Andrew A.

Address:

United States (US)

2

Name:

Gedulin Bronislava

Address:

United States (US)

3

Name:

Beeley Nigel Robert Arnold

Address:

United States (US)

4

Name:

Prickett Kathryn S.

Address:

United States (US)

Priority

Priority Number:

694954

Priority Date:

08/08/1996

Priority Country:

United States (US)

Classification

Main IPC Class:

A61K 38/00;

Publication

European Patent Bulletin

Issue number:

201813

Publication date:

28/03/2018

Description:

Revocation of the European patent

Filing date	Document type	Number of pages